Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
34 min
Explore the latest breakthroughs, guidance and treatment strategies in polypoidal choroidal vasculopathy (PCV). Credit available for this activity expires: 11/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/polypoidal-choroidal-vasculopathy-how-second-generation-2026a100155b?ecd=bdc_podcast_libsyn_mscpedu
23 min
Discover oral incretins as alternatives in obesity care. Credit available for this activity expires: 11/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/oral-vs-injectable-navigating-patient-choice-weight-2026a10014pl?ecd=bdc_podcast_libsyn_mscpedu
55 min
How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimers-care-live-case-based-forum-amyloid-2026a1001215?ecd=bdc_podcast_libsyn_mscpedu
The newest 50 of 632 episodes
34 min
Explore the latest breakthroughs, guidance and treatment strategies in polypoidal choroidal vasculopathy (PCV). Credit available for this activity expires: 11/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/polypoidal-choroidal-vasculopathy-how-second-generation-2026a100155b?ecd=bdc_podcast_libsyn_mscpedu
23 min
Discover oral incretins as alternatives in obesity care. Credit available for this activity expires: 11/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/oral-vs-injectable-navigating-patient-choice-weight-2026a10014pl?ecd=bdc_podcast_libsyn_mscpedu
55 min
How should our neurology clinics be fully prepared to integrate amyloid-targeting therapies (ATTs) into everyday, real-world practice? Credit available for this activity expires: 10/26/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/european-alzheimers-care-live-case-based-forum-amyloid-2026a1001215?ecd=bdc_podcast_libsyn_mscpedu
31 min
Using real-world patient case examples, hear from expert faculty on how they would navigate treatment choices using the latest data for patients with ATTR-CM. Credit available for this activity expires: 10/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/deciphering-clinical-data-transthyretin-cardiac-amyloidosis-2026a100110n?ecd=bdc_podcast_libsyn_mscpedu
28 min
A molecular clock is ticking in your patients with metastatic breast cancer. Are you listening? Credit available for this activity expires: 10/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010phecd=bdc_podcast_libsyn_mscpedu
45 min
Discover how novel therapies and expert consensus on the KDIGO framework are revolutionizing IgAN management to slow disease progression. Credit available for this activity expires: 10/13/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-iga-nephropathy-management-evolving-treatment-2026a10010le?ecd=bdc_podcast_libsyn_mscpedu
31 min
ADCs are moving from the metastatic setting into curative-intent neoadjuvant and adjuvant lines of treatment. Are you ready? Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/antibody-drug-conjugate-therapy-early-breast-cancer-2026a10010lp?ecd=bdc_podcast_libsyn_mscpedu
36 min
Do you know who to test, when to test, and which biomarker test to use? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/solving-alzheimers-disease-biomarker-puzzle-live-european-2026a1000y9g?ecd=bdc_podcast_libsyn_mscpedu
32 min
Do you know how to meet the challenges of treating uveitic macular edema? Credit available for this activity expires: 9/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-uveitic-macular-edema-management-whats-new-2026a1000y92?ecd=bdc_podcast_libsyn_mscpedu
59 min
Move beyond supportive care with targeted therapies for immunoglobulin A nephropathy (IgAN) management. Credit available for this activity expires: 09/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journeys-iga-nephropathy-optimizing-outcomes-patient-2026a1000xq5?ecd=bdc_podcast_libsyn_mscpedu
52 min
How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more. Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu
48 min
Can CAR T-cell therapies achieve drug-free remission in severe refractory autoimmune diseases? Credit available for this activity expires: 9/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-journey-severe-refractory-autoimmune-rheumatic-2026a1000xbu?ecd=bdc_podcast_libsyn_mscpedu
35 min
Are you up to speed on the latest updates on molecular-guided therapies in HR-positive/HER2-negative metastatic breast cancer (MBC)? Join us to learn more. Credit available for this activity expires: 9/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/translating-molecular-insights-practice-hr-positive-her2-2026a1000y0g?ecd=bdc_podcast_libsyn_mscpedu
29 min
Discover how emerging targeted therapies address systemic drivers in MASLD and MASH. Credit available for this activity expires: 9/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/targeting-metabolic-driver-forward-looking-approach-obesity-2026a1000t0l?ecd=bdc_podcast_libsyn_mscpedu
42 min
Fatigue, unpredictability, and life goals; integrate what patients say they need into how you treat myasthenia gravis (MG). Credit available for this activity expires: 9/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/whole-patient-integrating-lived-experience-myasthenia-gravis-2026a1000rf7?ecd=bdc_podcast_libsyn_mscpedu
47 min
Are your epilepsy patients achieving true seizure freedom, or is it time to adjust their therapy? Credit available for this activity expires: 9/1/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/epilepsy-general-neurology-practice-optimizing-therapeutic-2026a1000rgh?ecd=bdc_podcast_libsyn_mscpedu
38 min
Compare global myasthenia gravis (MG) guidelines to optimize local, patient-centered treatment pathways. Credit available for this activity expires: 8/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/myasthenia-gravis-guidelines-global-view-local-practice-2026a1000q15?ecd=bdc_podcast_libsyn_mscpedu
18 min
Are non-factor therapies enough to protect your hemophilia A patients during surgery? Credit available for this activity expires: 8/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanism-management-applying-evidence-hemophilia-clinic-2026a1000p5z?ecd=bdc_podcast_libsyn_mscpedu
41 min
Master multimodality imaging and autonomic red flag screening in your transthyretin amyloid cardiomyopathy (ATTR-CM) practice. Episode learning points & Disclosures: https://www.medscape.org/viewarticle/updating-our-checklist-transthyretin-amyloid-cardiomyopathy-2026a1000pul?ecd=bdc_podcast_libsyn_mscpedu
39 min
What tests are best to assess early cognitive symptoms? Credit available for this activity expires: 03/05/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003254?ecd=bdc_podcast_libsyn_mscpedu
27 min
Explore emerging B-cell-targeted therapies for immunoglobulin A nephropathy (IgAN). Unpack novel mechanisms of action (MOAs) and the latest clinical data to protect kidneys now. Credit available for this activity expires: 8/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/why-target-april-iga-nephropathy-management-get-speed-2026a1000ooh?ecd=bdc_podcast_libsyn_mscpedu
32 min
Are you up to date on developments in technology for treating retinovascular disease? Credit available for this activity expires: 7/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-intervals-next-era-continuous-delivery-retinal-2026a1000mm4?ecd=bdc_podcast_libsyn_mscpedu
26 min
Gain expert insights on how best to implement GDMT for your patients in the transition from hospitalization to post-discharge. Credit available for this activity expires: 7/22/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/when-and-how-should-i-optimize-heart-failure-treatments-my-2026a1000ngg?ecd=bdc_podcast_libsyn_mscpedu
35 min
Update PFIC care, from genetic diagnosis to guideline-recommended management. Credit available for this activity expires: 7/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/evolving-diagnostic-and-management-landscape-progressive-2026a1000mlz?ecd=bdc_podcast_libsyn_mscpedu
33 min
Master the latest evidence-based meds and dual therapies to help your patients quit for good. Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-interventions-nicotine-2026a1000ldi?ecd=bdc_podcast_libsyn_mscpedu
29 min
Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/normalizing-hemostasis-achievable-goal-hemophilia-2026a1000jxv?ecd=bdc_podcast_libsyn_mscpedu
17 min
Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/top-5-errors-transthyretin-amyloid-cardiomyopathy-management-2026a1000jpe?ecd=bdc_podcast_libsyn_mscpedu
37 min
Learn to optimize durability and drying with new second-generation anti-VEGF therapies. Credit available for this activity expires: 6/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/better-drying-longer-lasting-second-generation-anti-vegf-2026a1000k53?ecd=bdc_podcast_libsyn_mscpedu
23 min
Do you know how tumor-agnostic therapies are helping to reshape cancer treatment pathways? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/shaping-future-precision-oncology-biomarker-driven-care-2026a1000jpk?ecd=bdc_podcast_libsyn_mscpedu
21 min
Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu
26 min
How does it feel to live with CIDP? Bridge the gap between metrics and patient reality. Align goals and improve outcomes via shared decision-making. Credit available for this activity expires: 6/4/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-inflammatory-demyelinating-polyradiculoneuropathy-2026a1000g2n?ecd=bdc_podcast_libsyn_mscpedu
29 min
Do you know how the different therapies act in hemophilia A? Credit available for this activity expires: 05/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu
22 min
Can you untangle the threads linking depression and neurological disease to effectively treat your patients? Credit available for this activity expires: 06/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/depression-and-neurological-diseases-whats-link-2026a1000dco?ecd=bdc_podcast_libsyn_mscpedu
31 min
What is lacking in the care of your patients with myasthenia gravis? Find out how novel pathology-targeting therapies can meet unmet needs. Credit available for this activity expires: 5/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/what-lies-beneath-generalized-myasthenia-gravis-exploring-2026a1000fuh?ecd=bdc_podcast_libsyn_mscpedu
1 hr 16 min
What do the latest clinical trial data tell us and how do they impact practice? Credit available for this activity expires: 5/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-new-frontiers-advanced-breast-cancer-milestones-2026a1000fu7?ecd=bdc_podcast_libsyn_mscpedu
29 min
Discover how dual sodium-glucose cotransporter 1/2 (SGLT1/2) inhibition can improve outcomes for your patients across the heart failure (HF) spectrum. Credit available for this activity expires: 05/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-sglt2-emerging-role-dual-sglt1-2-inhibition-heart-2026a1000es7?ecd=bdc_podcast_libsyn_mscpedu
30 min
Keep up with the move toward targeted disease modifying therapies in Sjögren's disease. Credit available for this activity expires: 05/12/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/addressing-unmet-needs-management-sj%C3%B6grens-disease-2026a1000dvs?ecd=bdc_podcast_libsyn_mscpedu
35 min
Recognize biliary atresia (BA) signs early to stop pediatric liver transplant. Gain expert insights on screening, diagnosis, and urgent referral pathways. Credit available for this activity expires: 05/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenges-and-opportunities-diagnostic-pathway-biliary-2026a1000bpb?ecd=bdc_podcast_libsyn_mscpedu
16 min
Improve real-world DME outcomes by mastering the interpretation of evolving biomarkers and the latest evidence on long-acting anti-VEGF therapies. Credit available for this activity expires: [04/28/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diabetic-macular-edema-express-q-whats-new-2026a1000czk?ecd=bdc_podcast_libsyn_mscpedu
17 min
Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection. Credit available for this activity expires: 4/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu
21 min
Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available? Credit available for this activity expires: 3/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-case-based-2026a10008y0?ecd=bdc_podcast_libsyn_mscpedu
36 min
Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu
33 min
Do you know when to suspect edema in uveitis and how to manage it? Credit available for this activity expires: 3/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-horizons-uveitic-macular-edema-2026a10007ij?ecd=bdc_podcast_libsyn_mscpedu
51 min
Do you know how to optimally identify, risk stratify, and treat your patients with obesity and MASLD or MASH? Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/metabolic-crossroads-navigating-obesity-liver-disease-axis-2026a10007kf?ecd=bdc_podcast_libsyn_mscpedu
37 min
What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer? Credit available for this activity expires: 3/9/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu
31 min
Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices Credit available for this activity expires: 3/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu
19 min
Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients? Credit available for this activity expires: 3/3/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu
35 min
Are you optimizing inhaler choice and technique to achieve better outcomes? Credit available for this activity expires: 2/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/prescription-practice-respiratory-diseases-overcoming-2026a100058h?ecd=bdc_podcast_libsyn_mscpedu
35 min
Do you know how person-centred care can help address the challenges faced by chronic lymphocytic leukaemia (CLL) patients? Credit available for this activity expires: 02/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cll-consultation-partnering-patients-person-centred-care-2026a10005ap?ecd=bdc_podcast_libsyn_mscpedu
37 min
Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer? Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu
–
0 ratings from members
Rate this podcast
Log in to rate and review the shows you listen to.
No reviews yet — be the first member to rate "Keeping Current".
This podcast, its content and its artwork are not owned by, affiliated with, or endorsed by Castquire.
Keep listening
Up next
